Aberrant expression and mutations of PANoptosis-related genes (PRGs), such as NLRP3, caspase-8, and TNFAIP3, have been identified across various cancers, with many PRGs acting as tumor risk factors. This evidence concerns the gene NLRP3 and cancer.